Protect from moisture, heat, and direct light exposure
Proc Natl Acad Sci U S A 2013;110:1869-74.ArticlePubMedPMC 124
One is Virta Health, which advertises its nutrition-focused weight management program as "a proven approach for deprescribing GLP-1s when clinically appropriate." A Virta-funded study assessed 154 people with Type 2 diabetes who stopped using GLP-1 medications but continued following Virta's program, concluding that their weight did not significantly increase after a year
In some cases, you may feel numbing of toes or fingers
Adding tesamorelin may provide incremental benefits for visceral fat and muscle preservation, but those benefits come with significant unknown risks
In the retatrutide trial data above, dysesthesia jumped from 8.8% at the 9 mg dose to 20.9% at the 12 mg dosea pattern that mirrors whats been seen with another GLP-1 medication at a higher dose